Determining the world with a fresh start—Silai Biology’s 2018 mid-year summary meeting was successfully held
Time: September 11, 2018 Author: This site
In the blink of an eye, half of the 2018 fiscal year has passed. Silai Company continues to seek change and innovation in the context of rapid industry upgrading. The company's R&D and technical team has gradually grown to support the company's original innovation; Biendi, as one of the four high-end pharmaceuticals, continues to lead the market driven by the annual strategy of "2018, Determining the World—Creating the Biendi Era of DMBP" ; The essential oil market is maturing day by day, putting us at the next frontier in the feed additive industry; Bile acids, as the first choice for hepatobiliary syndrome, have huge market potential.
From September 9th to 11th, 2018, the 2018 Mid-term Summary Meeting of Silai Biology was successfully held in Chengdu. Each department of the company systematically summarized the work in the first half of fiscal year 2018 and carefully planned the plan for the second half of fiscal year 2018.
On the morning of September 10th, the mid-year summary meeting officially began. General Manager Wang Feng made an opening report with the title "A new start will determine the world." The report reviewed the strategy for the 2018 fiscal year, took stock of the company's sales progress in the first half of 2018, and analyzed the system. It identified the challenges and opportunities faced by the company in the context of rapid industry upgrading, and proposed strategies for the second half of 2018.
Subsequently, Dr. Yang Hanbo, Director of Technology Center, Dr. Wang Jianping, Director of R&D Center, Jiang Yong, Manager of Production Center, Zhao Mingjiang, Director of Marketing Department, and Peng Li, Manager of Financial Center, respectively summarized the work of their respective departments.
On the afternoon of September 10th, the sales system review officially started. General Manager of Noben Leilei, General Manager of the Pig Industry Line Chen Xianfeng, General Manager of the Poultry Industry Line Yan Fengge, General Manager of the Aquatic Product Line Zhu Huanqing, Key Account Division South China Manager Pu Dong, and Da Lu Jian, West China Region Manager of the Customer Business Department, and Wu Yujun, Director of the Commercial Business Department, respectively summarized the business development of each department in the first half of 2018.
On the morning of September 11, the theme of the meeting focused on the company and product market strategies. Director Zhao Mingjiang, Director Yang Hanbo, Manager Shuaike, and Manager Wang Xing respectively took stock of the market strategy for the 2018 fiscal year from the company and the product levels they were responsible for, and clarified the market strategy for the second half of 2018. Strategy.
On the afternoon of September 11th, the meeting was scheduled for "Market and Technology Sharing". Sharing on topics such as "Data on China's Animal Husbandry Industry", "Sharing of Creep Feed Conference", "Application of Unconventional Feed Raw Materials in Poultry", etc. further strengthened the company's Expertise of relevant personnel. At this point, Silai Biotech’s 2018 mid-term summary meeting has come to a successful conclusion.
2018 is destined to be an eventful year for the livestock industry, with the Sino-US trade war, the African swine fever incident, and rumors of a trend of reducing resistance getting closer. Each one will have a significant impact on our feed, breeding and related businesses. Silai Biotechnology insists on building an "integrated solution expert for high-quality intestinal health" in the rolling torrent, and provides cost-effective products and services for the industry chain, hoping that our families can eat meat, eggs and milk with confidence.
